SC Filed 2018-02-13 Event — SEC 0000903423-18-000104 →

GLAXOSMITHKLINE PLC → GENOCEA BIOSCIENCES, INC.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on GENOCEA BIOSCIENCES, INC.

Filed	Form	Filer	Stake	Shares
2021-04-14	SC	New Enterprise Associates 16, L.P.	—	—	view →
2020-08-03	SC	New Enterprise Associates 16, L.P.	—	—	view →
2019-02-22	SC	New Enterprise Associates 16, L.P.	—	—	view →
2019-02-14	SC	Polaris Venture Partners V, L.P.	—	—	view →

Other Filings by GLAXOSMITHKLINE PLC

Filed	Form	Issuer	Stake	Shares
2023-10-10	SC	Haleon plc HLNCF	—	—	view →
2022-11-14	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2022-09-20	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-09-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2021-02-12	SC	Innoviva, Inc. INVA	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-22	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2019-04-18	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →